Association of Cardiovascular Risk Factors with Microvascular and Conduit Artery Function in Hypertensive Subjects

Iftikhar Jan Kullo, A. Rauoof Malik, Simone Santos, Jo Ellen Ehrsam, Stephen T Turner

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

Background: Alterations in microvascular and conduit artery function contribute to target organ damage in hypertension. We investigated the association of cardiovascular (CV) risk factors with microvascular and conduit artery function in hypertensive subjects. Methods: Participants included 504 hypertensives (aged 62.1 ± 9.8 years, 42% men) from the community, without history of symptomatic CV disease. Brachial artery ultrasound was performed to measure forearm blood flow (FBF) at rest and during reactive hyperemia (markers of microvascular function) and flow-mediated dilatation (FMD) of the brachial artery (a marker of conduit artery endothelial function). The association of conventional and novel (homocysteine, C-reactive protein, fibrinogen, and lipoprotein a CV risk factors with microvascular function and FMD was tested in multivariable regression models. Results: Variables independently associated with higher resting FBF were male sex, higher body mass index (BMI), smoking, and lower HDL-cholesterol; variables associated with lower hyperemic FBF included greater age, female sex, and diabetes. Higher plasma homocysteine was associated with lower hyperemic FBF in obese subjects (P for log homocysteine × BMI interaction = .0008). Variables independently associated with lower FMD were greater age, sex gender, history of smoking, and not using statins. Higher homocysteine was associated with lower FMD in subjects with higher systolic blood pressure (P for interaction = .0004). Hyperemic flow velocity was independently associated with FMD (P = .0006), but its inclusion as a covariate did not influence the association of CV risk factors with FMD. Conclusions: In asymptomatic subjects with essential hypertension, select CV risk factors were associated with microvascular and conduit artery function. Furthermore, the association of CV risk factors with conduit artery function appeared to be independent of downstream microvascular function.

Original languageEnglish (US)
Pages (from-to)735-742
Number of pages8
JournalAmerican Journal of Hypertension
Volume20
Issue number7
DOIs
StatePublished - Jul 2007

Fingerprint

Dilatation
Arteries
Homocysteine
Forearm
Brachial Artery
Body Mass Index
Smoking
Hypertension
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Lipoprotein(a)
Hyperemia
C-Reactive Protein
Fibrinogen
HDL Cholesterol
Cardiovascular Diseases
Blood Pressure

Keywords

  • Blood flow
  • flow-mediated dilatation
  • reactive hyperemia
  • risk factors

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Association of Cardiovascular Risk Factors with Microvascular and Conduit Artery Function in Hypertensive Subjects. / Kullo, Iftikhar Jan; Malik, A. Rauoof; Santos, Simone; Ehrsam, Jo Ellen; Turner, Stephen T.

In: American Journal of Hypertension, Vol. 20, No. 7, 07.2007, p. 735-742.

Research output: Contribution to journalArticle

@article{9271336bf12940f2b7d8ed0cde5c69d1,
title = "Association of Cardiovascular Risk Factors with Microvascular and Conduit Artery Function in Hypertensive Subjects",
abstract = "Background: Alterations in microvascular and conduit artery function contribute to target organ damage in hypertension. We investigated the association of cardiovascular (CV) risk factors with microvascular and conduit artery function in hypertensive subjects. Methods: Participants included 504 hypertensives (aged 62.1 ± 9.8 years, 42{\%} men) from the community, without history of symptomatic CV disease. Brachial artery ultrasound was performed to measure forearm blood flow (FBF) at rest and during reactive hyperemia (markers of microvascular function) and flow-mediated dilatation (FMD) of the brachial artery (a marker of conduit artery endothelial function). The association of conventional and novel (homocysteine, C-reactive protein, fibrinogen, and lipoprotein a CV risk factors with microvascular function and FMD was tested in multivariable regression models. Results: Variables independently associated with higher resting FBF were male sex, higher body mass index (BMI), smoking, and lower HDL-cholesterol; variables associated with lower hyperemic FBF included greater age, female sex, and diabetes. Higher plasma homocysteine was associated with lower hyperemic FBF in obese subjects (P for log homocysteine × BMI interaction = .0008). Variables independently associated with lower FMD were greater age, sex gender, history of smoking, and not using statins. Higher homocysteine was associated with lower FMD in subjects with higher systolic blood pressure (P for interaction = .0004). Hyperemic flow velocity was independently associated with FMD (P = .0006), but its inclusion as a covariate did not influence the association of CV risk factors with FMD. Conclusions: In asymptomatic subjects with essential hypertension, select CV risk factors were associated with microvascular and conduit artery function. Furthermore, the association of CV risk factors with conduit artery function appeared to be independent of downstream microvascular function.",
keywords = "Blood flow, flow-mediated dilatation, reactive hyperemia, risk factors",
author = "Kullo, {Iftikhar Jan} and Malik, {A. Rauoof} and Simone Santos and Ehrsam, {Jo Ellen} and Turner, {Stephen T}",
year = "2007",
month = "7",
doi = "10.1016/j.amjhyper.2007.01.015",
language = "English (US)",
volume = "20",
pages = "735--742",
journal = "American Journal of Hypertension",
issn = "0895-7061",
publisher = "Oxford University Press",
number = "7",

}

TY - JOUR

T1 - Association of Cardiovascular Risk Factors with Microvascular and Conduit Artery Function in Hypertensive Subjects

AU - Kullo, Iftikhar Jan

AU - Malik, A. Rauoof

AU - Santos, Simone

AU - Ehrsam, Jo Ellen

AU - Turner, Stephen T

PY - 2007/7

Y1 - 2007/7

N2 - Background: Alterations in microvascular and conduit artery function contribute to target organ damage in hypertension. We investigated the association of cardiovascular (CV) risk factors with microvascular and conduit artery function in hypertensive subjects. Methods: Participants included 504 hypertensives (aged 62.1 ± 9.8 years, 42% men) from the community, without history of symptomatic CV disease. Brachial artery ultrasound was performed to measure forearm blood flow (FBF) at rest and during reactive hyperemia (markers of microvascular function) and flow-mediated dilatation (FMD) of the brachial artery (a marker of conduit artery endothelial function). The association of conventional and novel (homocysteine, C-reactive protein, fibrinogen, and lipoprotein a CV risk factors with microvascular function and FMD was tested in multivariable regression models. Results: Variables independently associated with higher resting FBF were male sex, higher body mass index (BMI), smoking, and lower HDL-cholesterol; variables associated with lower hyperemic FBF included greater age, female sex, and diabetes. Higher plasma homocysteine was associated with lower hyperemic FBF in obese subjects (P for log homocysteine × BMI interaction = .0008). Variables independently associated with lower FMD were greater age, sex gender, history of smoking, and not using statins. Higher homocysteine was associated with lower FMD in subjects with higher systolic blood pressure (P for interaction = .0004). Hyperemic flow velocity was independently associated with FMD (P = .0006), but its inclusion as a covariate did not influence the association of CV risk factors with FMD. Conclusions: In asymptomatic subjects with essential hypertension, select CV risk factors were associated with microvascular and conduit artery function. Furthermore, the association of CV risk factors with conduit artery function appeared to be independent of downstream microvascular function.

AB - Background: Alterations in microvascular and conduit artery function contribute to target organ damage in hypertension. We investigated the association of cardiovascular (CV) risk factors with microvascular and conduit artery function in hypertensive subjects. Methods: Participants included 504 hypertensives (aged 62.1 ± 9.8 years, 42% men) from the community, without history of symptomatic CV disease. Brachial artery ultrasound was performed to measure forearm blood flow (FBF) at rest and during reactive hyperemia (markers of microvascular function) and flow-mediated dilatation (FMD) of the brachial artery (a marker of conduit artery endothelial function). The association of conventional and novel (homocysteine, C-reactive protein, fibrinogen, and lipoprotein a CV risk factors with microvascular function and FMD was tested in multivariable regression models. Results: Variables independently associated with higher resting FBF were male sex, higher body mass index (BMI), smoking, and lower HDL-cholesterol; variables associated with lower hyperemic FBF included greater age, female sex, and diabetes. Higher plasma homocysteine was associated with lower hyperemic FBF in obese subjects (P for log homocysteine × BMI interaction = .0008). Variables independently associated with lower FMD were greater age, sex gender, history of smoking, and not using statins. Higher homocysteine was associated with lower FMD in subjects with higher systolic blood pressure (P for interaction = .0004). Hyperemic flow velocity was independently associated with FMD (P = .0006), but its inclusion as a covariate did not influence the association of CV risk factors with FMD. Conclusions: In asymptomatic subjects with essential hypertension, select CV risk factors were associated with microvascular and conduit artery function. Furthermore, the association of CV risk factors with conduit artery function appeared to be independent of downstream microvascular function.

KW - Blood flow

KW - flow-mediated dilatation

KW - reactive hyperemia

KW - risk factors

UR - http://www.scopus.com/inward/record.url?scp=34250629191&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34250629191&partnerID=8YFLogxK

U2 - 10.1016/j.amjhyper.2007.01.015

DO - 10.1016/j.amjhyper.2007.01.015

M3 - Article

C2 - 17586407

AN - SCOPUS:34250629191

VL - 20

SP - 735

EP - 742

JO - American Journal of Hypertension

JF - American Journal of Hypertension

SN - 0895-7061

IS - 7

ER -